Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Siri Lagethon Heck, Albulena Mecinaj, Anne Hansen Ree, Pavel Hoffmann, Jeanette Schulz-Menger, Morten Wang Fagerland, Berit Gravdehaug, Helge Røsjø, Kjetil Steine, Jürgen Geisler, Geeta Gulati and Torbjørn Omland